1 Introduction Brain is a major body organ that integrate several neurodegenerative diseases including Alzheimer disease (AD), Parkinson disease (PD), primary tauopathies, frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), synucleinopathies (such as Lewy body dementia [LBD] and multisystem atrophy [MSA]), polyglutamine-related diseases (Huntington disease (HD) and spinocerebellar ataxias [SCA]), prion disease (PrD), traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE), spinal cord injury (SCI), and multiple sclerosis (MS) (Wilson et al., 2023)
Crit Rev Biochem Mol Biol 52(3):340354 de Souza GF et al (2006) Leishmanicidal activity of primary S -nitrosothiols against Leishmania major and Leishmania amazonensis : implications for the treatment of cutaneous leishmaniasis
In controlled research settings, Epithalon-based peptides have been studied for their influence on telomerase activity, circadian rhythm regulation, and gene expression modulation
AOPPadvanced oxidation protein product plasma levels
M.KohY.HongS
The expansion of neurodegenerative disease-associated clinical trial infrastructure in low/middle-income countries is equally essential, as the burden of age-related diseases is rising sharply
